News | Information Technology | September 29, 2023

Fuse also announces Syntyant, a new interoperable platform for RadOnc providing seamless connectivity among diverse healthcare technologies to accelerate delivery of care 

Fuse also announces Syntyant, a new interoperable platform for RadOnc providing seamless connectivity among diverse healthcare technologies to accelerate delivery of care

September 29, 2023 — Fuse Oncology (Fuse) a trailblazing leader in radiation oncology software solutions, unveils their latest pioneering product, FuseDocs, today. This groundbreaking software leverages generative artificial intelligence (AI) to transform radiation oncology documentation, allowing oncologists to refocus their energies on patient care.  

FuseDocs automatically and effortlessly generates clinical documentation, drastically reducing the time needed to produce essential records. By accurately generating the correct documents at the right time, human errors are reduced while ensuring compliance with regulatory requirements.  

President of Radiation Oncology Associates, PC, and the emeritus Chairman and Medical Director of the Department for Advanced Radiation Oncology and Proton Therapy for Inova Schar Cancer Institute Gopal K. Bajaj, MD MBA FASTRO said, “Fuse is not only introducing a product—they are ushering in a new era of efficiency and innovation in radiation oncology. Their mission is clearly being realized—to empower radiation oncologists to provide the best care possible, and FuseDocs is a significant step in that direction.”  

FuseDocs represents a pivotal advancement in the field of radiation oncology. By replacing template-based approaches with fully automated documentation that leverages generative AI, the administrative burden is significantly reduced—empowering radiation oncologists to focus on what truly matters— providing exceptional patient care.  

“We’re excited to introduce FuseDocs to the radiation oncology community at ASTRO,” said Fuse CEO James Bauler. “Our software leverages generative AI to create unprecedented efficiencies, enabling radiation oncologists to invest their time and talent in patient care, unburdened by administrative tasks. FuseDocs moves RadOnc one step closer to delivering care at the speed of the patient.”  

FuseDocs builds upon the success of Fuse’s existing product, S!GNAL, which is creating a RadOnc world where workflows are automatically monitored for consistent adherence. A simple secure dashboard provides real-time feedback to assist healthcare systems and RadOnc clinics discover revenue opportunities by detecting missing documentation, incomplete tasks and errors in charge capture.  

Along with FuseDocs, Fuse also unveiled today their interoperable platform for RadOnc, Syntyant, which provides seamless connectivity among diverse healthcare technologies including EMR, OIS, and planning systems to accelerate delivery of care.  

Fuse will be at booth #1618 at the ASTRO conference from October 1-4 to showcase their suite of products and offer live FuseDocs demos.   

For more information: www.fuseonc.com 

Find more ASTRO23 conference coverage here


Related Content

News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Proton Therapy

Sept. 28, 2026 — Penn Medicine and Ion Beam Applications (IBA) have formed Noventra Oncology Alliance, a new joint ...

Time September 28, 2026
arrow
News | ASTRO

Sept. 22, 2026 — Leading experts in radiation therapy from the Abramson Cancer Center (ACC) of the University of ...

Time September 24, 2026
arrow
News | RSNA

Sept. 22, 2026 — The Radiological Society of North America (RSNA) is now offering a certificate program that equips ...

Time September 24, 2026
arrow
News | Molecular Imaging

Sept. 22, 2026 — Blue Earth Diagnostics, a part of the Bracco Group, has announced new research examining how precision ...

Time September 23, 2026
arrow
News | ASTRO

Sept.16, 2026 — For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a ...

Time September 17, 2026
arrow
News | Ultrasound Imaging

Sept. 16, 2026 — Ultrasound AI, Inc., a developer of artificial intelligence for medical imaging with a focus on ...

Time September 17, 2026
arrow
News | CT Angiography (CTA)

Sept. 15, 2026 — A new study published in the Journal of the American College of Radiology (JACR) found that an ...

Time September 15, 2026
arrow
News | Radiology Imaging

Sept. 1, 2026 — Leo Cancer Care and GE HealthCare have announced that the two companies intend to work together on GE ...

Time September 11, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
Subscribe Now